Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2] Share Buyback Summary - On October 23, 康臣药业 repurchased 422,000 shares at a price range of HKD 14.740 to HKD 15.040, totaling HKD 6.2941 million [2] - The stock closed at HKD 14.980 on the same day, reflecting a decrease of 2.73% with a total trading volume of HKD 26.6429 million [2] - Since October 14, the company has conducted buybacks for 8 consecutive days, acquiring a total of 2.011 million shares for a cumulative amount of HKD 30.7041 million, during which the stock price fell by 6.38% [2] - Year-to-date, 康臣药业 has completed 26 buyback transactions, repurchasing a total of 7.206 million shares for a total expenditure of HKD 89.2351 million [2] Detailed Buyback Data - The buyback details include various dates, number of shares repurchased, highest and lowest prices, and total amounts spent, showcasing a consistent buyback strategy [3]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - 康臣药业 plans to repurchase 422,000 shares at a total cost of HKD 6.2941 million [1] - The buyback price ranges from HKD 14.74 to HKD 15.04 per share [1] Financial Implications - The total expenditure for the buyback reflects a strategic move to enhance shareholder value [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年10月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有 ...

Core Viewpoint - On October 22, 35 Hong Kong-listed companies conducted share buybacks, totaling 10.4965 million shares and an amount of 52.7745 million HKD [1][2]. Group 1: Buyback Details - The company with the highest buyback amount on October 22 was AAC Technologies, with a buyback amount of 11.9098 million HKD for 300,000 shares [1][2]. - Linklogis Technology-W followed with a buyback of 2.430 million shares, amounting to 7.4708 million HKD [1][2]. - Mengniu Dairy repurchased 500,000 shares for 7.1714 million HKD [1][2]. Group 2: Year-to-Date Buyback Totals - AAC Technologies has conducted multiple buybacks this year, with a cumulative buyback amount of 858.628 million HKD [2]. - Linklogis Technology-W's total buyback amount for the year reached 225.0668 million HKD [2]. - Mengniu Dairy's year-to-date buyback amount stands at 45.832 million HKD [2]. Group 3: Buyback Volume Rankings - The highest number of shares repurchased on October 22 was by Linklogis Technology-W, with 2.43 million shares [1][2]. - Other notable buybacks in terms of volume included MorningX Technology with 1.064 million shares and China Hengyou Group with 1 million shares [1][2].

Summary of Key Points Core Viewpoint - A total of 30 companies, including major players like 瑞声科技 (AAC Technologies) and 蒙牛乳业 (Mengniu Dairy), conducted share buybacks on October 22, 2025, indicating a trend of companies returning capital to shareholders amidst market conditions. Group 1: Buyback Details - 瑞声科技 (AAC Technologies) had the largest buyback amount, repurchasing 300,000 shares for a total of 11.90 million yuan [1] - 联易融科技-W (Lianyi Technology) repurchased 2.43 million shares, totaling 7.47 million yuan, representing 3.288% of its total share capital [2] - 蒙牛乳业 (Mengniu Dairy) bought back 500,000 shares for 7.17 million yuan, which is 0.517% of its total share capital [2] Group 2: Other Notable Buybacks - 康臣药业 (Kangchen Pharmaceutical) repurchased 283,000 shares for 4.33 million yuan, accounting for 7.969% of its total share capital [2] - 连连数字 (Lianlian Digital) bought back 440,000 shares for 3.54 million yuan, which is 0.138% of its total share capital [2] - 固生堂 (Gushengtang) repurchased 91,300 shares for 2.75 million yuan, representing 2.076% of its total share capital [2] Group 3: Additional Companies Involved - 绿城服务 (Greentown Service) repurchased 216,000 shares for 989,300 yuan, which is 0.007% of its total share capital [2] - 歌礼制药-B (Galactico Pharmaceutical) bought back 100,000 shares for 926,500 yuan, accounting for 0.068% of its total share capital [2] - 医渡科技 (Yidu Technology) repurchased 17,700 shares for 99,800 yuan, representing 0.330% of its total share capital [2]

| 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.10.22 | 28.30 | 15.400 | 15.150 | 433.08 | | 2025.10.21 | 26.90 | 15.600 | 15.440 | 417.00 | | 2025.10.20 | 10.00 | 15.470 | 15.390 | 154.13 | | 2025.10.17 | 31.70 | 15.200 | 14.970 | 477.91 | | 2025.10.16 | 20.00 | 15.600 | 15.540 | 311.82 | | 2025.10.15 | 10.00 | 15.840 | 15.490 | 157.57 | | 2025.10.14 | 32.00 | 15.620 | 15.140 | 489.51 | | 2025.07.18 | 10.00 | 12.300 | 12.160 | 122.72 | | 2025.07.16 | 5.00 | 11.7 ...

康臣药业(01681)发布公告，于2025年10月22日，该公司斥资433.08万港元回购28.3万股。 ...

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - 康臣药业 plans to repurchase 283,000 shares at a total cost of HKD 4.3308 million [1]

Core Viewpoint - 康臣药业 announced a share buyback of 283,000 shares at a cost of HKD 4.331 million on October 22 [1] Company Summary - 康臣药业 executed a buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback was HKD 4.331 million, reflecting the company's strategy to manage its capital structure [1] - The number of shares repurchased was 283,000, which may influence the company's stock performance and market perception [1]

FF305 | 320,000 | 0.0377 % | HKD | 15.2972 | | --- | --- | --- | --- | | 100,000 | 0.0118 % | HKD | 15.7565 | 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年10月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. ...